Sensory processing abnormalities are consistently observed in autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and ...
Hadley Johnson ’25 has been selected for the NIH Oxford-Cambridge Scholars Program (OxCam), a transatlantic partnership ...
Watch a preview of the next episode of A World of Difference: Embracing Neurodiversity. Watch a preview of the next episode of A World of Difference: Embracing Neurodiversity.
According to new research, the wiring of the brain may be even more complex than we knew. Have you ever been lost in the woods and felt as if you were going in circles? New research in the journal ...
Your risk of cognitive decline and dementia rises with small amounts of ultraprocessed foods, even when you are trying to eat ...
The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.
MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results